These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20001630)

  • 1. Blood transfusion: quality and safety issues in thalassemia, basic requirements and new trends.
    Porter J
    Hemoglobin; 2009; 33 Suppl 1():S28-36. PubMed ID: 20001630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell transfusions for thalassemia: results of a survey assessing current practice and proposal of evidence-based guidelines.
    Goss C; Giardina P; Degtyaryova D; Kleinert D; Sheth S; Cushing M
    Transfusion; 2014 Jul; 54(7):1773-81. PubMed ID: 24611697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in Transfusion Requirements Among Children With Thalassemia on Regular Transfusion Programs: Which Formula Closely Predicts the Actual Requirements?
    Cornell N; Eisenhut M; Ramprakash S
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):e388-e390. PubMed ID: 28060132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia.
    Fasano RM; Branscomb J; Lane PA; Josephson CD; Snyder AB; Eckman JR
    Transfus Med; 2019 Jun; 29(3):185-192. PubMed ID: 30740798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).
    Vichinsky E; Neumayr L; Trimble S; Giardina PJ; Cohen AR; Coates T; Boudreaux J; Neufeld EJ; Kenney K; Grant A; Thompson AA;
    Transfusion; 2014 Apr; 54(4):972-81; quiz 971. PubMed ID: 23889533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India.
    Makroo RN; Arora JS; Chowdhry M; Bhatia A; Thakur UK; Minimol A
    Indian J Pathol Microbiol; 2013; 56(4):378-83. PubMed ID: 24441225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatitis C virus infection in thalassemia.
    Butensky E; Pakbaz Z; Foote D; Walters MC; Vichinsky EP; Harmatz P
    Ann N Y Acad Sci; 2005; 1054():290-9. PubMed ID: 16339677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalassemia.
    Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion reactions in thalassemia. A survey from the Cooleycare programme. The Cooleycare Cooperative Group.
    Rebulla P
    Haematologica; 1990; 75 Suppl 5():122-7. PubMed ID: 2086372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of iron overload in thalassemia.
    Piomelli S; Graziano J
    Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
    Tanphaichitr A; Kusuwan T; Limviriyakul S; Atipas S; Pooliam J; Sangpraypan T; Tanphaichitr VS; Viprakasit V
    Hemoglobin; 2014; 38(5):345-50. PubMed ID: 25051423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion in critically ill children: indications, risks, and challenges.
    Parker RI
    Crit Care Med; 2014 Mar; 42(3):675-90. PubMed ID: 24534955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Incidence Rate of Acute Transfusion Reactions in Thalassemia Patients Referred to the Shiraz Thalassemia Centre, Shiraz, Iran, Before and After the Establishment of the Hemovigilance System.
    Kasraian L; Karimi MH
    Hemoglobin; 2015; 39(4):274-80. PubMed ID: 26036919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan.
    Wang LY; Liang DC; Liu HC; Chang FC; Wang CL; Chan YS; Lin M
    Transfus Med; 2006 Jun; 16(3):200-3. PubMed ID: 16764599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies on iron chelation in patients with thalassemia major.
    Freedman MH; Olivieri N; Benson L; Liu P; McClelland R; St Louis P; Templeton D; Koren G
    Haematologica; 1990; 75 Suppl 5():74-83. PubMed ID: 2086384
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-dependent thalassemia: viral complications (epidemiology and follow-up).
    de Montalembert M; Girot R; Mattlinger B; Lefrère JJ
    Semin Hematol; 1995 Oct; 32(4):280-7. PubMed ID: 8560285
    [No Abstract]   [Full Text] [Related]  

  • 20. A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan.
    Ho WL; Chung KP; Yang SS; Lu MY; Jou ST; Chang HH; Yang YL; Lin DT; Lin KH
    J Formos Med Assoc; 2013 Apr; 112(4):221-9. PubMed ID: 23537869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.